Articles By Trisha Gladd

41. BDP Week Highlights The Importance Of Communication In BioPharma 4/4/2014

    At this year’s Biopharmaceutical Development and Production (BDP) Week, March 24-27 at the Hilton Bayfront Hotel, I attended several sessions that focused on how to strengthen the relationship between partners in the pharmaceutical industry. One overwhelming theme in each presentation was the importance of communicating effectively and clearly with everyone involved in a project.

42. Where Do Ideas Come From? Time Is Money, So Spend It Wisely 4/3/2014

    In a traditional office environment, hours upon hours are often spent collaborating with other people to come up with game-changing ideas. Even the time spent alone at your desk can be occupied with juggling multiple responsibilities and tasks. It’s usually only during downtime at the end of the day, whether it’s a quiet ride home in the car or lying in bed at night, that we allow ourselves time to relax and reflect. Tony and Oliver Stauffer, president and chief operating officer at Packaging Technology & Inspections, as well as father and son, believe it’s during these moments to ourselves that we have the ability to come up with some of our best ideas.

43. Where Do Ideas Come From? Sometimes, From Places You'd Least Expect 3/14/2014

    As part of the Where Do Ideas Come From? series, I spoke with Tony Pidgeon, senior manager of global science and technology at Patheon, a pharmaceutical contract manufacturer and development company, about not only where he gets his ideas, but also what he does once he has them.

44. FDA And Industry Experts Offer Guidance For DQSA Preparation 3/3/2014

    It’s been over three months since President Obama signed the Drug Quality and Security Act (DQSA) into law, and some of the industry is still unsure how to proceed with preparation for Title II, which outlines the plan for supply chain security. In a recent discussion with Pharmaceutical Online, Ilisa Bernstein, Pharm.D, JD, Deputy Director of the U.S. FDA Office of Compliance in the Center for Drug Evaluation and Research (CDER), encouraged the industry to familiarize itself with the law and the requirements under it.

45. Out With The Old, In With The New: GSK's Smart Workplace 2/24/2014

    By eliminating the confines of the traditional workspace, companies can encourage better employee interaction and collaboration. Will this be the key for an industry counting on innovation to lead it into the future?

46. QbD: Lessons Learned From An FDA Filing 2/24/2014

    Implementing quality by design offers not only a proactive approach to product development, but also the opportunity to streamline your filing process.

47. Success Requires Risk 2/24/2014

    Recently, I began a series on the Pharmaceutical Online website exploring where good ideas come from, because they often come at times or from places we’d least expect. While talking to some of the most innovative people I’ve met in this industry, I discovered an overwhelming theme resonating from each of their stories. Innovators believe that one of the greatest tools to success is the ability to learn from your mistakes. By embracing failure, instead of fearing it, you allow yourself the freedom to take risks, which can lead to possibilities you would’ve never considered. Being innovative isn’t just a catchy adjective — it’s an attitude.

48. A CDMO's Plan For The Future Of Biologics 1/28/2014

    When narrowing the field of potential manufacturing partners, finding one that is flexible enough to respond to increased production requirements in an ever-changing industry is imperative. After all, that is the reason many outsource in the first place. Peter Soelkner, managing director of Vetter, believes being flexible is not just the ability to respond to a client’s current needs but also being prepared to meet their future needs.

49. Where Do Ideas Come From? Create A Culture That Fosters Good Ideas 1/9/2014

    We live in a fast-paced world driven by technology and competition, but in order to really stay ahead, we have to be able to slow down and think. We have to allow our minds the time to create good ideas. So how do we do this?

50. Pfizer Collaboration Prepares For The Future Of Flexible Manufacturing 11/20/2013

    With the landscape of the industry shifting toward the need for more flexibility, pharma companies are exploring more ways to keep pace with this demand while still keeping costs low. In a recent announcement, GEA Process Engineering, G-CON Manufacturing, and Pfizer revealed how they’re addressing this challenge — a Portable Continuous Miniature & Modular (PCMM) manufacturing collaboration.